000 01358 a2200397 4500
005 20250514041118.0
264 0 _c20021002
008 200210s 0 0 eng d
022 _a1527-2737
024 7 _a10.1007/s11934-002-0051-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGhafar, Mohamed A
245 0 0 _aDoes the prostatic vascular system contribute to the development of benign prostatic hyperplasia?
_h[electronic resource]
260 _bCurrent urology reports
_cAug 2002
300 _a292-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdrenergic alpha-Antagonists
_xtherapeutic use
650 0 4 _aAndrogens
_xphysiology
650 0 4 _aAnimals
650 0 4 _aApoptosis
650 0 4 _aCell Division
650 0 4 _aCell Hypoxia
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProstate
_xblood supply
650 0 4 _aProstatic Hyperplasia
_xdrug therapy
650 0 4 _aRats
650 0 4 _aRegional Blood Flow
650 0 4 _aUrodynamics
_xphysiology
700 1 _aPuchner, Peter J
700 1 _aAnastasiadis, Aristotelis G
700 1 _aCabelin, Mark A
700 1 _aButtyan, Ralph
773 0 _tCurrent urology reports
_gvol. 3
_gno. 4
_gp. 292-6
856 4 0 _uhttps://doi.org/10.1007/s11934-002-0051-2
_zAvailable from publisher's website
999 _c12036278
_d12036278